Similarly, CAR-T cells transduced with trastuzumab scFv efficiently lyse HER2-positive cancer cells, such as MCF-7 HER2 cells (genetically engineered to express HER2) and SK-BR-3 cells (27). The gene discussed is ERBB2; the disease is cancer.